PubRank

R N Boswell

Author PubWeight™ 52.27‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant. Science 1990 6.77
2 Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging. J Clin Invest 1989 3.92
3 Detection of cytotoxic T lymphocytes specific for synthetic peptides of gp160 in HIV-seropositive individuals. J Immunol 1991 2.17
4 Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals. Nature 1989 1.80
5 Delayed-type hypersensitivity skin testing predicts progression to AIDS in HIV-infected patients. Ann Intern Med 1993 1.79
6 Common epitope in human immunodeficiency virus (HIV) I-GP41 and HLA class II elicits immunosuppressive autoantibodies capable of contributing to immune dysfunction in HIV I-infected individuals. J Clin Invest 1989 1.77
7 In vitro T cell function, delayed-type hypersensitivity skin testing, and CD4+ T cell subset phenotyping independently predict survival time in patients infected with human immunodeficiency virus. J Infect Dis 1995 1.69
8 Patterns of virus burden and T cell phenotype are established early and are correlated with the rate of disease progression in human immunodeficiency virus type 1-infected persons. J Infect Dis 1996 1.22
9 Spectrum of cerebrospinal fluid findings in various stages of human immunodeficiency virus infection. Arch Neurol 1988 1.21
10 Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant: further clarifications. Science 1991 1.14
11 Use of a resin-bound synthetic peptide for identifying a neutralizing antigenic determinant associated with the human immunodeficiency virus envelope. J Biol Chem 1987 1.07
12 Cerebrospinal fluid abnormalities in patients without AIDS who are seropositive for the human immunodeficiency virus. J Infect Dis 1988 1.04
13 Neuropsychological and neurological function of human immunodeficiency virus seropositive asymptomatic individuals. Arch Neurol 1989 0.98
14 Comparison of antibody reactivity to human immunodeficiency virus type 1 (HIV-1) gp160 epitopes in sera from HIV-1-infected individuals from Tanzania and from the United States. J Clin Microbiol 1992 0.98
15 Increased Epstein-Barr virus DNA in oropharyngeal secretions from patients with AIDS, AIDS-related complex, or asymptomatic human immunodeficiency virus infections. J Infect Dis 1988 0.98
16 Synthetic peptides define the fine specificity of the human immunodeficiency virus (HIV) gp160 humoral immune response in HIV type 1-infected chimpanzees. J Virol 1990 0.96
17 Multiple patterns of alloantigen presenting/stimulating cell dysfunction in patients with AIDS. J Immunol 1991 0.96
18 Longitudinal analysis of the humoral immune response to human immunodeficiency virus type 1 (HIV-1) gp160 epitopes in rapidly progressing and nonprogressing HIV-1-infected subjects. J Infect Dis 1993 0.96
19 A chemotactic receptor for val(ala)-gly-ser-glu on human. Immunol Commun 1976 0.92
20 Accessory cell function in asymptomatic human immunodeficiency virus-infected patients. Clin Immunol Immunopathol 1990 0.91
21 Comparison by race of total serum IgG, IgA, and IgM with CD4+ T-cell counts in North American persons infected with the human immunodeficiency virus type 1. J Acquir Immune Defic Syndr 1992 0.91
22 Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant: corrections and clarifications. Science 1991 0.90
23 Intermediate molecular weight eosinophil chemotactic factors in rat peritoneal mast cells: immunologic release, granule association, and demostration of structura heterogeneity. J Immunol 1978 0.90
24 Multivariate models for predicting progression to AIDS and survival in human immunodeficiency virus-infected persons. J Infect Dis 1995 0.90
25 Patterns of antibody reactivity to selected human immunodeficiency virus type 1 (HIV-1) gp160 epitopes infected individuals grouped according to CD4+ cell levels. J Clin Immunol 1991 0.90
26 Nonallergic rhinitis with eosinophilia (NARES syndrome). Clinical and immunologic presentation. J Allergy Clin Immunol 1981 0.89
27 Immunization with subunit human immunodeficiency virus vaccine generates stronger T helper cell immunity than natural infection. Eur J Immunol 1991 0.87
28 The relationship of serum IgA concentration to human immunodeficiency virus (HIV) infection: a cross-sectional study of HIV-seropositive individuals detected by screening in the United States Air Force. J Allergy Clin Immunol 1988 0.87
29 Enhanced serological and virological findings of Epstein-Barr virus in patients with AIDS and AIDS-related complex. J Infect Dis 1986 0.86
30 Serum IgE levels in 622 persons with human immunodeficiency virus infection: IgE elevation with marked depletion of CD4+ T-cells. AIDS Res Hum Retroviruses 1990 0.85
31 Early lymphocyte transformation abnormalities in human immunodeficiency virus infection. J Clin Immunol 1989 0.83
32 CSF changes in a longitudinal study of 124 neurologically normal HIV-1-infected U.S. Air Force personnel. J Acquir Immune Defic Syndr 1991 0.83
33 Increased serum neopterin in patients with HIV-1 infection is correlated with reduced in vitro interleukin-2 production. Clin Exp Immunol 1990 0.82
34 Cerebrospinal fluid anti-cardiolipin antibodies in patients with HIV-1 infection. J Acquir Immune Defic Syndr 1991 0.82
35 Psychiatric illness at all stages of human immunodeficiency virus infection. Am J Psychiatry 1988 0.81
36 Comparison of spinal fluid beta 2-microglobulin levels with CD4+ T cell count, in vitro T helper cell function, and spinal fluid IgG parameters in 163 neurologically normal adults infected with the human immunodeficiency virus type 1. J Infect Dis 1991 0.80
37 Cutaneous manifestations of early human immunodeficiency virus exposure. J Am Acad Dermatol 1988 0.80
38 Negative correlation between blood cell counts and serum neopterin concentration in patients with HIV-1 infection. AIDS 1991 0.79
39 Chest pain variant asthma. Ann Emerg Med 1983 0.78
40 Transcriptional effects of superinfection in HIV chronically infected T cells: studies in dually infected clones. J Acquir Immune Defic Syndr Hum Retrovirol 1996 0.78
41 HLA-DR+ CD8+ T cells in the cerebrospinal fluid of a patient with AIDS dementia complex and 355-494/mm3 CD4+ peripheral blood T cells. J Acquir Immune Defic Syndr 1991 0.77
42 Circumvention of defective CD4 T helper cell function in HIV-infected individuals by stimulation with HLA alloantigens. J Immunol 1990 0.77
43 Pseudofailure of zidovudine prophylaxis after a human immunodeficiency virus-positive needlestick. J Infect Dis 1990 0.77
44 The natural history of human immunodeficiency virus infection in screened HIV positive U.S. Air Force personnel: a preliminary report. J Acquir Immune Defic Syndr 1988 0.76
45 Early markers of HIV infection and subclinical disease progression. Vaccine 1993 0.75
46 Hepatitis C antibody in a non-hemophiliac cohort infected with the human immunodeficiency virus. Viral Immunol 1990 0.75
47 In vivo and in vitro comparison of fire ant venom and fire ant whole body extract. J Allergy Clin Immunol 1983 0.75
48 Cardiovascular risk modification: a multidisciplinary approach in a USAF clinic setting. Mil Med 1986 0.75
49 Goodpasture's syndrome associated with pulmonary eosinophilic vasculitis. J Rheumatol 1988 0.75
50 AIDS in Arkansas. AIDS 1988. J Ark Med Soc 1988 0.75
51 CD4+ monocyte counts in persons with HIV-1 infection: an early increase is followed by a progressive decline. J Acquir Immune Defic Syndr 1991 0.75
52 Expansion of restricted cellular immune responses to HIV-1 envelope by vaccination: IL-7 and IL-12 differentially augment cellular proliferative responses to HIV-1. Clin Exp Immunol 1997 0.75